Charles Schwab’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.4M Sell
385,647
-9,349
-2% -$336K ﹤0.01% 1918
2026
Q1
$12.7M Buy
394,996
+17,548
+5% +$645K ﹤0.01% 1991
2025
Q4
$14.5M Sell
377,448
-2,455
-0.6% -$53.9K ﹤0.01% 1944
2025
Q3
$5.22M Buy
379,903
+69,870
+23% +$820K ﹤0.01% 2426
2025
Q2
$4.01M Sell
310,033
-12,771
-4% -$133K ﹤0.01% 2422
2025
Q1
$3.63M Sell
322,804
-4,800
-1% -$63K ﹤0.01% 2409
2024
Q4
$4.29M Buy
327,604
+599
+0.2% +$15.4K ﹤0.01% 2401
2024
Q3
$13.1M Buy
327,005
+143,389
+78% +$5.21M ﹤0.01% 1906
2024
Q2
$5.42M Buy
+183,616
New +$5M ﹤0.01% 2325

Other funds holding PACS

Charles Schwab's PACS Position: Q2 2026 in Review

Charles Schwab reduced its PACS Group (PACS) stake by 2.4% in Q2 2026, selling an estimated $336K and leaving 385,647 shares worth $16.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1918.

Charles Schwab first reported a position in PACS in Q2 2024 and has held it in 9 quarters since. 239 funds tracked by Wall St. Rank hold PACS as of Q2 2026.

  • Charles Schwab held 385,647 shares of PACS Group worth $16.4M as of Q2 2026.
  • Charles Schwab sold 9,349 PACS Group shares in Q2 2026, an estimated $336K.
  • PACS Group made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #1918 holding.
  • Charles Schwab first reported a position in PACS Group in Q2 2024 and has held it in 9 quarters since.
  • 239 funds tracked by Wall St. Rank held PACS Group as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.